Active substanceSennosides A and BSennosides A and B
Similar drugsTo uncover
  • Herbion® Laxana
    pills inwards 
  • Senadé®
    pills inwards 
    Cipla Ltd.     India
  • Senales
    pills inwards 
  • Sennagood
    pills inwards 
    AVVA RUS, OJSC     Russia
  • Ex-Lax
    lozenges inwards 
    Novartis ExLax Inc.     Puerto Rico
  • Dosage form: & nbsppills
    Composition:
    1 tablet contains:
    Senna leaf extract is dry, as a sum of calcium salts of sennosides A and B in terms of sennoside B ** 13.5 mg Excipients: sodium carboxymethyl starch, starch, silicon dioxide colloid, croscarmellose, lactose, talc.
    Form of issue
    For 20 tablets in a blister of PVC / Paper with a polymer coating. For 2 or 3 blisters together with instructions for use in a pack of cardboard.
    For 20 or 25 blisters together with instructions for use in a pack of cardboard (for hospitals).

    Description:
    Round flat tablets with bevelled edges and risk on the one hand, brown, it is allowed the presence of inclusions of a darker color.

    Pharmacotherapeutic group:laxative herbal remedy
    ATX: & nbsp

    A.06.A.B   Contact laxatives

    Pharmacodynamics:
    Has a stable effect, coming in 6-12 hours. The laxative effect is due to the effect on the receptors of the large intestine, which increases peristalsis, which leads to a faster evacuation of the intestine.

    Indications:
    Constipation caused by atony, hypotension and sluggish peristalsis of the large intestine. Regulation of stool with hemorrhoids, proctitis, anal fissures.

    Contraindications:
    Hypersensitivity to the components of the drug, intestinal obstruction, strangulated hernia, acute inflammatory diseases of the abdominal cavity (including peritonitis), gastrointestinal bleeding, metrorrhagia, spastic constipation, cystitis, violation of water-electrolyte metabolism, children under 6 years.

    Carefully:
    Pregnancy, lactation, hepatic and / or renal failure, conditions after abdominal operations.

    Dosing and Administration:
    Inside, usually once a day before going to bed, washing down with water.
    Adults and children over 12 years: 1-2 tablets. If there is no effect, the dose can be increased to 3 tablets per reception.
    Children 6-12 years: for 1 \ 2-1 tablet and, if necessary, increase the dose to 2 tablets.
    In the process of selection, one and the same dose should be taken for several days and gradually increase it by UV tablets. If after reaching the maximum dose within 3 days of the effect is not achieved, you need to see a doctor.

    Side effects:
    The laxative effect of the drug may be accompanied by colic pain in the abdomen, flatulence. With long-term use, especially in high doses, there may be a disturbance of the water electrolyte balance, proteinuria, hematuria, melanin deposits in the intestinal mucosa, nausea, vomiting, diarrhea, urine discoloration, skin rash, fatigue, convulsions, vascular collapse, confusion.

    Interaction:
    With prolonged use in high doses, it is possible to increase the action of cardiac glycosides and the effect on the action of antiarrhythmic drugs in connection with the possibility of developing hypokalemia.
    With simultaneous use with thiazide diuretics, glucocorticosteroids with licorice root preparations, the risk of hypokalemia increases.
    Violates the absorption of tetracyclines.

    Special instructions:
    It is not recommended to use the drug for more than 2 weeks.

    Form release / dosage:

    tablets 15.5 mg
    Packaging:
    For 20 tablets in a blister of PVC / Paper with a polymer coating. For 3 blisters together with instructions for use in a pack of cardboard.
    For 20 blisters together with instructions for use in a pack of cardboard (for hospitals).
    Storage conditions:
    At a temperature of no higher than 25 ° C, in a dry place.Keep out of the reach of children.

    Shelf life:
    3 years. Do not use after the expiry date printed on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:П N012885 / 01
    Date of registration:21.01.2008
    The owner of the registration certificate:Outline Pharma Pvt. Ltd.Outline Pharma Pvt. Ltd. India
    Manufacturer: & nbsp
    Representation: & nbspNPK Katren AONPK Katren AORussia
    Information update date: & nbsp16.09.2015
    Illustrated instructions
      Instructions
      Up